Shivam Chemicals Ltd
Incorporated in 2012, Shivam Chemicals Ltd is in the business of wholesale sale of feed ingredients[1]
- Market Cap ₹ 185 Cr.
- Current Price ₹ 109
- High / Low ₹ 130 / 56.0
- Stock P/E 38.4
- Book Value ₹ 24.6
- Dividend Yield 0.00 %
- ROCE 15.4 %
- ROE 12.3 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 4.44 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 79 | 96 | 177 | 157 | 136 | 207 | 270 | |
| 78 | 94 | 171 | 151 | 133 | 203 | 263 | |
| Operating Profit | 1 | 2 | 6 | 5 | 3 | 4 | 7 |
| OPM % | 2% | 2% | 4% | 3% | 2% | 2% | 2% |
| 0 | 0 | 0 | 0 | 0 | 1 | 2 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 1 | 6 | 5 | 3 | 3 | 6 |
| Tax % | 36% | 32% | 25% | 27% | 29% | 25% | 26% |
| 1 | 1 | 4 | 4 | 2 | 3 | 5 | |
| EPS in Rs | 20.50 | 21.75 | 112.25 | 93.00 | 1.62 | 1.51 | 2.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 20% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 9% |
| TTM: | 88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 76% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 12% |
| Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.40 | 0.40 | 0.40 | 0.40 | 12 | 17 | 17 |
| Reserves | 4 | 5 | 10 | 13 | 3 | 20 | 25 |
| 3 | 2 | 5 | 7 | 11 | 10 | 18 | |
| 1 | 3 | 8 | 3 | 7 | 7 | 7 | |
| Total Liabilities | 9 | 10 | 24 | 24 | 34 | 54 | 66 |
| 1 | 0 | 0 | 0 | 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 2 | 2 | 7 | 7 |
| 8 | 9 | 23 | 22 | 32 | 46 | 58 | |
| Total Assets | 9 | 10 | 24 | 24 | 34 | 54 | 66 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 2 | -3 | -2 | -4 | -11 | -7 | ||
| 0 | -0 | -1 | -0 | -5 | -0 | ||
| -2 | 3 | 4 | 4 | 16 | 6 | ||
| Net Cash Flow | -0 | 0 | -0 | -0 | 0 | -1 | |
| Free Cash Flow | 2 | -3 | -2 | -4 | -11 | -7 | |
| CFO/OP | 117% | -23% | -16% | -96% | -246% | -78% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 29 | 27 | 29 | 28 | 40 | 41 | 34 |
| Inventory Days | 1 | 0 | 0 | 0 | 0 | 7 | 7 |
| Days Payable | 4 | 9 | 15 | 18 | 10 | 6 | |
| Cash Conversion Cycle | 26 | 19 | 14 | 28 | 22 | 39 | 36 |
| Working Capital Days | 28 | 20 | 22 | 27 | 37 | 50 | 46 |
| ROCE % | 22% | 57% | 30% | 13% | 13% | 15% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Average Monthly Sales Volume MT |
|
||
| Cumulative Historical Supply Volume Metric Tons |
|||
| Installed Manufacturing Capacity MT per annum |
|||
| Manufacturing Volume Growth % |
|||
| Trading and Distribution Volume Growth % |
|||
Extracted by Screener AI
Documents
Announcements
-
Outcome Of Board Meeting Held To Consider And Approve Audited Financial Results For The Half Year And Year Ended 31St March, 2026
28 May - Board approved audited standalone and consolidated results for half year and year ended 31 March 2026; unmodified opinion.
-
Board Meeting Outcome for Outcome Of Board Meeting Held To Consider And Approve Audited Financial Results For The Half Year And Year Ended 31St March, 2026
28 May - Board approved audited standalone and consolidated FY2026 results; auditor issued unmodified opinion.
-
Board Meeting Intimation for To Consider, Adopt And Approve Audited Standalone And Consolidated Financial Results For The Half Year And Year Ended 31St March, 2026 And Other Matters
23 May - Board meeting on 28 May 2026 to approve audited standalone and consolidated results for FY2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Submitted Regulation 74(5) depository certificate for quarter ended 31 March 2026.
-
Closure of Trading Window
27 Mar - Trading window closed from 1 April 2026 until 48 hours after results for year ended 31 Mar 2026.
Business Overview:[1]
SCL manufactures Hydrated Lime (Calcium Hydroxide) and distributes various products like Poultry Feed Supplement (MBM), Di-Calcium Phosphate (Feed Grade), Magnesium Oxide, and Limestone Powder. With a marketing network across India, SCL distributes animal feed products for multiple manufacturers and has supplied over 2.50 lakh metric tons of various products valued at Rs. 750 Crs.